S100A4 and urinary bladder carcinoma: For instance, Franzen et al. proved that bladder cancer-derived EVs increased the expression of several mesenchymal markers (including α-smooth muscle actin, S100A4, and snail), as well as the motility and invasiveness of normal recipient uroepithelial cells [6].